GENR can't recommend to chase but if falls below $4 here are the triggers which will make much "motion": 1. New patent announcement. 2. More Squalamine test results for AMD. 3. IL9 test results for asthma. 4. LOMUCIN test results for cystic fibrosis. 5. Major brokerage coverage. 6. Drug partnership for Squalamine.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.